Worldwide AI in Healthcare Industry to 2026 – Competitive Analysis and the Impact of COVID-19

0
17

Dublin, June 17, 2021 (GLOBE NEWSWIRE) — The “Global AI in Healthcare Market (2021-2026) by Sections, Diagnosis, End-user, Geography, Competitive Analysis and the Impact of COVID-19 with Ansoff Analysis” report has been added to ResearchAndMarkets.com’s offering.

The Global AI in Healthcare Market size is expected to grow from USD 6.1 Bn in 2021 and reach USD 39.5 Bn by 2026; it is projected to grow at a CAGR of 45.3%.

The increasing volume of healthcare data and growing complexities of datasets driving the need for AI, the intensifying need to reduce towering healthcare costs, improving computing power and declining hardware costs, growing number of cross-industry partnerships and collaborations, and rising imbalance between health workforce and patients driving the need for improvised healthcare services.

Another major factor fueling the market growth currently is the adoption of this technology by multiple pharmaceutical and biotechnology companies across the world to expedite vaccine or drug development processes for COVID-19. Artificial intelligence in healthcare is one of the most important scientific advancements in medicine so far. The participation of several start-ups in the development of AI-driven imaging and diagnostic solutions is a key factor contributing to the growth of the sector.

Market Segmentation

The Global Artificial Intelligence in Diagnostics Market is segmented further based on Sections, Diagnosis, End user and Geography.

By Sections, the market is classified into Services, Software and Hardware. Software segment to hold the largest share in AI in healthcare market.

By Diagnosis, the market is classified into Radiology, Oncology, Neurology, Cardiology, Chest & Lungs, Pathology and Other Diagnosis Types.

By End User, the market is classified amongst Hospitals & Healthcare Providers. Patients, Pharmaceuticals & Biotechnology Companies, Healthcare Payers, Others (ACOS and MCOS.

By Geography, North America is a key artificial intelligence in healthcare market.

Recent Developments
1. In March 2020, IBM Watson Health and EBSCO Information Services partnered to provide access to evidence-based drug and disease information that can help support clinicians and individuals as they cope with infectious diseases, including COVID-19.
2. In July 2019, IBM acquired RedHat. Red Hat’s open hybrid cloud technologies are now paired with IBM’s innovation and industry expertise. IBM and Red Hat will accelerate innovation by offering a next-generation hybrid multi-cloud platform. Based on open source technologies, such as Linux and Kubernetes, the platform will allow businesses to securely deploy, run, and manage data and applications on premises and on private and multiple public clouds.
3. Jun-2020: GE Healthcare announced collaboration with Lunit, a South Korean startup. Together with Lunit, GE launched an artificial intelligence-powered chest X-ray analysis suite. The suite has been designed to spot and highlight eight common conditions, using algorithms built by Lunit.
4. Jul-2020: AliveCor introduced KardiaCare, a digital health subscription service. The service provides members the control and convenience of managing heart health at home. This new service delivers exclusive digital tools to make it easier for users to interpret their heart data, monitor risk factors, identify symptom triggers, and measure the impact of positive lifestyle changes as part of a long-term heart care program.

Company Profiles

Some of the companies covered in this report are NVIDIA Corporation (NVIDIA) (US), Intel Corporation (Intel) (US), International Business Machines Corporation (IBM) (US), Google Inc. (Google) (US), Microsoft Corporation (Microsoft) (US), Amazon Web Services (an Amazon.com, Inc. subsidiary) (AWS) (US), General Vision, Inc. (US), General Electric (GE) Healthcare (US), Siemens Healthineers (Germany), Medtronic plc (US), Johnson & Johnson Services, Inc. (Johnson & Johnson) (US), and Koninklijke Philips N.V. (Netherlands) etc.

Competitive Quadrant

The report includes a Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.

Why buy this report?

  • The report offers a comprehensive evaluation of the Global Artificial Intelligence In Diagnostics Market.
  • The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.
  • The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.
  • The report includes in-depth market analysis using Porter’s 5 force model and the Ansoff Matrix. The impact of Covid-19 on the market is also featured in the report.
  • The report also contains the competitive analysis using Competitive Quadrant, the analyst’s proprietary competitive positioning tool.

Report Highlights:

  • A complete analysis of the market, including parent industry
  • Important market dynamics and trends
  • Market segmentation
  • Historical, current, and projected size of the market based on value and volume
  • Market shares and strategies of key players
  • Recommendations to companies for strengthening their foothold in the market

Key Topics Covered:

1 Report Description

2 Research Methodology

3 Executive Summary

4 Market Overview
4.1 Introduction
4.2 Market Dynamics
4.2.1 Drivers
4.2.1.1 Influx of large and complex healthcare datasets
4.2.1.2 Growing need to reduce healthcare costs
4.2.1.3 Improving computing power and declining hardware cost
4.2.1.4 Growing number of cross-industry partnerships and collaborations
4.2.1.5 Rising need for improvised healthcare services due to imbalance between health workforce and patients
4.2.2 Restraints
4.2.2.1 Reluctance among medical practitioners to adopt AI-based technologies
4.2.2.2 Lack of skilled AI workforce and ambiguous regulatory guidelines for medical software
4.2.3 Opportunities
4.2.3.1 Growing potential of AI-based tools for elderly care
4.2.3.2 Increasing focus on developing human-aware AI systems
4.2.3.3 Growing potential of AI-technology in genomics, drug discovery, and imaging & diagnostics to fight COVID-19
4.2.4 Challenges
4.2.4.1 Lack of curated healthcare data
4.2.4.2 Concerns regarding data privacy
4.2.4.3 Lack of interoperability between AI solutions offered by different vendors
4.3 Trends

5 Market Analysis
5.1 Porter’s Five Forces Analysis
5.2 Impact of COVID-19
5.3 Ansoff Matrix Analysis

6 Global Artificial Intelligence In Diagnostics Market, By Section
6.1 Introduction
6.2 Hardware
6.3 Software
6.4 Services

7 Global Artificial Intelligence In Diagnostics Market, By Diagnosis
7.1 Introduction
7.2 Radiology
7.3 Pathology
7.4 Cardiology
7.5 Oncology
7.6 Neurology
7.7 Chest and Lung
7.8 Others

8 Global Artificial Intelligence In Diagnostics Market, By End User
8.1 Hospitals & Healthcare Providers
8.2 Patients
8.3 Pharmaceuticals & Biotechnology Companies
8.4 Healthcare Payers
8.5 Others (ACOS and MCOS)

9 Global Artificial Intelligence In Diagnostics Market, By Geography
9.1 Introduction
9.2 North America
9.2.1 US
9.2.2 Canada
9.2.3 Mexico
9.3 South America
9.3.1 Brazil
9.3.2 Argentina
9.4 Europe
9.4.1 UK
9.4.2 France
9.4.3 Germany
9.4.4 Italy
9.4.5 Spain
9.4.6 Rest of Europe
9.5 Asia-Pacific
9.5.1 China
9.5.2 Japan
9.5.3 India
9.5.4 Indonesia
9.5.5 Malaysia
9.5.6 South Korea
9.5.7 Australia
9.5.8 Russia
9.5.9 Rest of APAC
9.6 Rest of the World
9.6.1 Qatar
9.6.2 Saudi Arabia
9.6.3 South Africa
9.6.4 United Arab Emirates
9.6.5 Latin America

10 Competitive Landscape
10.1 Competitive Quadrant
10.2 Market Share Analysis
10.3 Competitive Scenario
10.3.1 Mergers & Acquisitions
10.3.2 Agreement, Collaborations, & Partnerships
10.3.3 New Product Launches & Enhancements
10.3.4 Investments & Funding

11 Company Profiles
11.1 NVIDIA Corporation (NVIDIA)
11.2 Intel Corporation (Intel)
11.3 IBM Corporation (IBM)
11.4 Google LLC (Google)
11.5 Microsoft Corporation (Microsoft)
11.6 General Electric X-ray Corporation (GE Healthcare)
11.7 Siemens Healthineers AG (Siemens Healthineers)
11.8 Medtronic Plc (Medtronic)
11.9 Micron Technologies
11.10 Amazon Web Services, Inc (AWS)
11.11 Johnson&Johnson
11.12 Koninklijke Philips N.V.
11.13 General Vision Services (GVS)
11.14 Cloudmex Inc. (Cloudmex)
11.15 Oncora Medical, Inc
11.16 Anju Life Sciences Software
11.17 CareSkore, Inc
11.18 Linguamatics (UK),
11.19 Enlitic, Inc.
11.20 Lunit Inc.
11.21 CureMetrix Inc.
11.22 Qure.ai Technologies Private Limited
11.23 Context Vision Operations
11.24 Caption Health
11.25 Butterfly Network Inc.
11.26 Imagia Cybernetics Inc.
11.27 Precision Health Intelligence, LLC.
11.28 Cota Healthcare
11.29 FDNA, Inc.
11.30 Recursion Pharmaceuticals, Inc.
11.31 Atomwise, Inc.
11.32 Deep Genomics Inc.
11.33 Cloud Pharmaceuticals
11.34 Welltok, Inc.
11.35 Vitagene, Inc.
11.36 Lucina Health, Inc.
11.37 Next IT Corp.
11.38 Babylon Health
11.39 MDLIVE Inc.
11.40 Magnea
11.41 Physiq, Inc.
11.42 CyrcadiaHealth
11.43 Caresyntax Inc.

12 Appendix

For more information about this report visit https://www.researchandmarkets.com/r/ngiw3n


LEAVE A REPLY

Please enter your comment!
Please enter your name here